| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 12/30/2010 | US20100331413 Therapeutic Formulations Based on Asiatic Acid and Selected Salts Thereof |
| 12/30/2010 | US20100331395 Decoy-containing pharmaceutical compositions and method of using the same |
| 12/30/2010 | US20100331385 Pyrazole urea derivatives used as kinase inhibitors |
| 12/30/2010 | US20100331359 Novel compound useful for the treatment of degenerative and inflammatory diseases |
| 12/30/2010 | US20100331350 Inhibitors of bruton's tyrosine kinase |
| 12/30/2010 | US20100331343 Novel triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors |
| 12/30/2010 | US20100331342 Immuno Inhibitory Pyrazolone Compounds |
| 12/30/2010 | US20100331337 Quercetin-Containing Compositions |
| 12/30/2010 | US20100331333 Imidazo [1,2-B] Pyridazine Compounds |
| 12/30/2010 | US20100331319 Novel compound useful for the treatment of degenerative and inflammatory diseases |
| 12/30/2010 | US20100331304 Compounds Which Modulate The CB2 Receptor |
| 12/30/2010 | US20100331302 N-(2-(hetaryl)aryl) arylsulfonamides and n-(2-(hetaryl)hetaryl arylsulfonamides |
| 12/30/2010 | US20100331301 Azetidine compound and pharmaceutical use thereof |
| 12/30/2010 | US20100331298 Carboxamide Compounds and Their Use |
| 12/30/2010 | US20100331293 Heterocyclic compounds and their uses |
| 12/30/2010 | US20100331286 Combination therapy for treatment of bone and mineral disorders for patients with impaired renal function |
| 12/30/2010 | US20100331285 Novel Polymorph of Acetylsalicylic Acid, and Methods of Making and Using the Same |
| 12/30/2010 | US20100331270 Adrenomedullin production enhancer |
| 12/30/2010 | US20100331257 Preparation of terminally-sterilized collagen that is soluble at neutral ph |
| 12/30/2010 | US20100331256 Variants of C-Type Natriuretic Peptides |
| 12/30/2010 | US20100331254 Pulverized fibrin clots and pharmaceutical compositions containing them |
| 12/30/2010 | US20100331252 Myostatin inhibitor enhancement of musculoskeletal repair |
| 12/30/2010 | US20100331251 Polypeptides homologous to vegf and bmp1 |
| 12/30/2010 | US20100331237 Gag binding proteins |
| 12/30/2010 | US20100331236 Cyclic peptides as g-protein coupled receptor antagonists |
| 12/30/2010 | US20100330673 Methods of making enhanced, autologous fat grafts |
| 12/30/2010 | US20100330213 Estrogenic Extracts of Morus Alba and Uses Thereof |
| 12/30/2010 | US20100330198 Aminosugar, glycosaminoglycan, and s-adenosylmethionine composition for the treatment and repair of connective tissue |
| 12/30/2010 | US20100330194 Silicon Substituted Phosphates |
| 12/30/2010 | US20100330182 Tendon Stem Cells |
| 12/30/2010 | US20100330179 Method for Treating a Patient at Risk for Developing an NSAID-associated Ulcer |
| 12/30/2010 | US20100330174 Betaine compositions |
| 12/30/2010 | US20100330159 System for transporting active substances in a biological system |
| 12/30/2010 | US20100330148 Mehods and compositions for inhibiting impdh-1 isoform 1 |
| 12/30/2010 | US20100330117 Process for treatment of amyotrophic lateral sclerosis, rheumatoid arthritis, tremors/parkinson's disease, multiple sclerosis, non-viral based cancers, alzheimers's disease, muscular dystrophy, attention deficit disorder, attention deficit hyperactivity disorder, complex regional pain syndrome, diabetes, neuropathic pain, spider arthritis, west nile virus, fibromyalgia, shingles, gout, migraine headaches, senile dementia, post polio syndrome, central virus deafness, asthma, chronic pain of unknown origin and hepatitis c |
| 12/30/2010 | US20100330110 Therapeutic and diagnostic uses of antibody specificity profiles |
| 12/30/2010 | US20100330090 Antagonist antibodies of protease activated receptor-1 (par1) |
| 12/30/2010 | US20100330085 Method of treatment, prophylaxis and diagnosis of pathologies of the bone |
| 12/30/2010 | US20100330077 1-acetic acid-indole derivatives with pgd2 antagonist activity |
| 12/30/2010 | US20100330072 Myostatin binding agents |
| 12/30/2010 | US20100330065 Compositions and methods for treating collagen-mediated diseases |
| 12/30/2010 | US20100330063 Stem-like cells, method for de-differentiating mammalian somatic cells into stem-like cells, and method for differentiating stem-like cells |
| 12/30/2010 | US20100330053 Mixed-cell gene therapy |
| 12/30/2010 | US20100330045 Mesenchymal precursor cell |
| 12/30/2010 | US20100330036 Markers of matrix gene expression and cellular differentiation in chondrocytes |
| 12/30/2010 | US20100329998 Novel heterocycles |
| 12/30/2010 | US20100329985 Treatment and prevention of inflammatory diseases and autoimmune diseases |
| 12/29/2010 | WO2010151338A2 Myostatin inhibitor enhancement of musculoskeletal repair |
| 12/29/2010 | WO2010151216A1 Method for treating a patient at risk for developing an nsaid-associated ulcer |
| 12/29/2010 | WO2010150837A1 Indoline derivative |
| 12/29/2010 | WO2010150612A1 Hyaluronic acid production promoter and melanin production inhibitor |
| 12/29/2010 | WO2010150525A1 Urate transporter, as well as method and kit for evaluating urate transport-related disease factor and inflammation-related disease factor, and test sample and drug |
| 12/29/2010 | WO2010149769A1 5-phenyl-[1,2,4 ]triazolo[1,5-a]pyridin-2-yl carboxamides as jak inhibitors |
| 12/29/2010 | WO2010149596A1 Compositions for treating degenerative joint diseases |
| 12/29/2010 | WO2010078730A9 Preparation of ginsenoside-rd propylene glycol aqueous solution and new use thereof in anti-inflammation, immunosuppression and anti organ-graft rejection |
| 12/29/2010 | WO2010078324A3 Companion animal compositions including lipoic acid and methods of use thereof |
| 12/29/2010 | EP2267445A1 Methods of detecting small intestinal bacterial overgrowth (SIBO) in a human subject |
| 12/29/2010 | EP2267032A2 Method of administering therapeutic polypeptides, and polypeptides therefor |
| 12/29/2010 | EP2267029A2 Methods and compositions for treatment of inflammatory disease using Cadherin-11 modulating agents |
| 12/29/2010 | EP2267027A2 Method of administering therapeutic polypeptides, and polypeptides therefor |
| 12/29/2010 | EP2267026A1 Albumin fusion proteins |
| 12/29/2010 | EP2266978A1 Novel physiologically active substances |
| 12/29/2010 | EP2266665A1 Method for the improvement of islet signaling in diabetes mellitus and for its prevention |
| 12/29/2010 | EP2266626A1 Composition for external application comprising transcription factor decoy as active ingredient |
| 12/29/2010 | EP2266624A2 Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections |
| 12/29/2010 | EP2266607A2 Immunoconjugates for treating cancer |
| 12/29/2010 | EP2266598A1 Method of increasing bone toughness and stiffness and reducing fractures |
| 12/29/2010 | EP2266585A2 Water-soluble strontium salts for use in treatment of cartilage and/or bone conditions |
| 12/29/2010 | EP2266584A2 Composition with strontium and vitamin D for the prophylaxis and/or treatment of cartilage and/or bone conditions |
| 12/29/2010 | EP2266578A1 Pharmaceutical composition for preventing and treating bone resorption of different etiology |
| 12/29/2010 | EP2266560A1 Benzothiophenes, formulations containing same, and methods |
| 12/29/2010 | EP2266551A1 Compositions and kits comprising a defined boron compound and methods of their preparation |
| 12/29/2010 | EP2266543A2 Non-polymeric hematopoietic cell clots for delivery of active agents |
| 12/29/2010 | EP2266540A1 Pharmaceutical compositions comprising a HMG COA reductase inhibitor |
| 12/29/2010 | EP2265644A1 A monoclonal antibody and a method thereof |
| 12/29/2010 | EP2265595A1 Novel flavonol compounds, a bioactive extract/fraction from ulmus wallichiana and its compounds for prevention for treatment of osteo-health related disorders |
| 12/29/2010 | EP2265584A1 Hydroxyalkanyl amides as modulators of chemokine receptor activity |
| 12/29/2010 | EP2265280A2 Preparation of a pharmaceutical composition for increasing bone mineral density |
| 12/29/2010 | EP2265279A1 Use of the pat nonapeptide in the treatment of autoimmune diseases |
| 12/29/2010 | EP2265277A1 Preparation and use of a plant extract from solanum glaucophyllum with an enriched content of 1,25-dihydroxyvitamin d3 glycosides and quercetin glycosides |
| 12/29/2010 | EP2265124A1 Aerosolized lfa-1 antagonists for use in localized treatment of immune related disorders |
| 12/29/2010 | EP1732575B1 Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions |
| 12/29/2010 | EP1692275B1 Method and system for preparing stem cells from fat tissue |
| 12/29/2010 | EP1530568B1 INDOLE OR BENZIMIDAZOLE DERIVATIVES FOR MODULATING I&kB KINASE |
| 12/29/2010 | EP1529062B1 Therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signal transduction |
| 12/29/2010 | EP1438052B1 Quinazolin-4-ones as inhibitors of human phosphatidylinositol 3-kinase delta |
| 12/29/2010 | EP1370530B1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical |
| 12/29/2010 | EP1362119B1 Glucosamine and method of making glucosamine from microbial biomass |
| 12/29/2010 | EP1107722B1 A method for the treatment of staphylococcal infection |
| 12/29/2010 | EP1001946B1 QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56lck TYROSINE KINASES |
| 12/29/2010 | CN1968691B Composition for acceleration of alcohol metabolism or recuperation from fatigue through gluconeogenesis |
| 12/29/2010 | CN1922139B Bicyclic amide derivatives |
| 12/29/2010 | CN101932603A Methods of treating bone-loss disorders using a gm-csf antagonist |
| 12/29/2010 | CN101932573A Novel pyridinones and pyridazinones |
| 12/29/2010 | CN101932314A New pharmaceutical formulation comprising cannabidiol and tetrahydrocannabidivarin |
| 12/29/2010 | CN101932306A Alendronate formulations, method of making and method of use thereof |
| 12/29/2010 | CN101928745A Preparation method and applications of ant polypeptide |
| 12/29/2010 | CN101928704A Polyethylene glycol modifier of aspergillus flavus urate oxidase and preparation method thereof |
| 12/29/2010 | CN101928328A RGD peptide-epimedium flavone combination, preparation method and application thereof |
| 12/29/2010 | CN101928287A Novel vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same |